Bharat Edition

Bharatstox

← All stocks

Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM · Healthcare

Sector

Healthcare

Size band

Large cap

Market cap

1,37,043cr

P/E

62.3

ROE

26.2%

Dividend yield

0.8%

No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.

Measured against

Operating margin34.0%
peer 20.5%
Revenue growth54.8%
peer 16.1%
Torrent Pharmaceuticals Ltd.peer median

Peer set

Pharmaceuticals & Drugs · largest 12 of 82 measured at Q1 FY27 · financials via Screener
CompanyOperating marginRevenue growth
Sun Pharmaceutical Industries Ltd.29.0%10.5%
Divi's Laboratories Ltd.41.0%27.8%
Torrent Pharmaceuticals Ltd.34.0%54.8%
Lupin Ltd.30.0%32.1%
Dr. Reddy's Laboratories Ltd.11.0%−5.5%
Cipla Ltd.17.0%2.3%
Zydus Lifesciences Ltd.24.0%22.0%
Mankind Pharma Ltd.26.0%12.9%
Aurobindo Pharma Ltd.21.0%16.3%
Torrent Power Ltd.19.0%2.8%
Alkem Laboratories Ltd.20.0%10.9%
Glenmark Pharmaceuticals Ltd.20.0%23.1%

No guidance on record.

This section quotes what management told the market on the quarterly earnings call. We have not transcribed one for Torrent Pharmaceuticals Ltd..

On air

20 calls · outcomes not tracked

Recorded as stated on air, with the analyst's SEBI registration status where it was given. Anchor calls carry no registration and are marked. Bharatstox does not make, endorse or repeat these calls, and none of them is our view.

Channel & showAiredStated targetStated stopOutcome
CNBC AwaazCNBC Awaax · no registration attached19 Oct+2.1%-1.0%still open
CNBC AwaazCNBC Awaax · no registration attached19 Oct+1.6%-1.0%still open
Zee BusinessZee Business · no registration attached7 Oct——still open
Zee BusinessZee Business · no registration attached7 Oct+0.9%-2.0%still open
Zee BusinessZee Business · no registration attached7 Oct+5.7%—still open
CNBC AwaazCNBC Awaax · no registration attached30 Sep-4.1%+2.3%still open
CNBC AwaazCNBC Awaax · no registration attached29 Sep-4.3%+2.0%still open
Zee BusinessZee Business · no registration attached28 Sep+26.3%-3.8%still open
Zee BusinessZee Business · no registration attached28 Sep+20.3%-3.8%still open
Zee BusinessZee Business · no registration attached27 Sep+26.3%-3.8%still open
Zee BusinessZee Business · no registration attached27 Sep+20.3%-3.8%still open
Zee BusinessZee Business · no registration attached26 Sep+26.3%-3.8%still open
Zee BusinessZee Business · no registration attached26 Sep+20.3%-3.8%still open
Zee BusinessZee Business · no registration attached25 Sep+26.3%-3.8%still open
Zee BusinessZee Business · no registration attached25 Sep+20.3%-3.8%still open
Zee BusinessZee Business · no registration attached25 Sep+2.0%-1.1%still open
CNBC AwaazCNBC Awaax · no registration attached22 Sep——still open
CNBC AwaazCNBC Awaax · no registration attached22 Sep+4.7%—still open
CNBC AwaazCNBC Awaax · no registration attached22 Sep+4.7%-2.5%still open
CNBC AwaazCNBC Awaax · no registration attached22 Sep+4.6%-2.5%still open

Shareholding

change across 4 filings
CategorySep 26Jul 26Jun 26Mar 26Change
Promoters60.860.868.368.3−7.5
Foreign institutions17.218.015.416.2+1.0
Domestic institutions13.512.99.89.1+4.4
Retail & others8.58.46.46.5+2.0

As filed with the exchange for the periods ending Mar 26 to Sep 26.

Filings

latest 25 of 303
  • Resignation of Director/KMP/SMP16 Oct 2026
    Medium impactResignationFiling PDF ↗
  • Change in Management16 Oct 2026
    Medium impactManagement ChangeFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates9 Oct 2026
    RoutineGeneralFiling PDF ↗
  • Credit Rating7 Oct 2026
    Medium impactCredit RatingFiling PDF ↗
  • Acquisition28 Sept 2026
    High impactM&AFiling PDF ↗
  • Trading Window28 Sept 2026
    Medium impactInsider TradingFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates10 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Intimation of Schedule of Investor Meets10 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Copy of Newspaper Publication9 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Newspaper advertisement in respect of special window for transfer and dematerialisation of physical shares9 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Shareholders meeting7 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Outcome of Postal Ballot7 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Scrutinizer''s Report on the Postal Ballot7 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates11 Aug 2026
    RoutineGeneralFiling PDF ↗
  • General Updates11 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Copy of Newspaper Publication6 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Shareholders meeting5 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates4 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates30 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Change in Management30 Jul 2026
    Medium impactManagement ChangeFiling PDF ↗
  • Press Release30 Jul 2026
    RoutineResultsFiling PDF ↗
  • Outcome of Board Meeting30 Jul 2026
    RoutineBoard MeetingFiling PDF ↗
  • Appointment28 Jul 2026
    Medium impactAppointmentFiling PDF ↗
  • General Updates27 Jul 2026
    RoutineGeneralFiling PDF ↗
  • General Updates20 Jul 2026
    High impactM&AFiling PDF ↗

The 25 most recent of 303 filings we hold for TORNTPHARM, back to January 2024. Every filing, by day.

Disclaimer

Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Broadcast calls are reproduced as stated on air, attributed, with the analyst's SEBI registration status where given; they are not our calls and not our view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.

Bharat ke stocks, har subah.

One daily brief on what India's SEBI-registered research analysts are calling. No noise, no spam, unsubscribe whenever.